Not Medicare Enrolled

Dr. Stephen Apaliski, M.D.

Allergy & Immunology · Arlington, TX
5421 MATLOCK RD, Arlington, TX 76018
8174607447
Registered in NPPES since 2006
NPI: 1801981642 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Apaliski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Apaliski? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Apaliski

Dr. Stephen Apaliski is an allergy & immunology specialist in Arlington, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Apaliski received a total of $5,917 from 34 pharmaceutical and/or device companies across 266 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Apaliski is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $5,917 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,917
Total received (2018-2024)
Avg $845/year across 7 years
Top 49% in TX for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
266
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$856
2023
$1,544
2022
$1,414
2021
$499
2020
$435
2019
$554
2018
$615

Payments by company (2024)

Novartis Pharmaceuticals Corporation
$189
Takeda Pharmaceuticals U.S.A., Inc.
$175
Regeneron Healthcare Solutions, Inc.
$133
GlaxoSmithKline, LLC.
$120
Grifols USA, LLC
$67
AstraZeneca Pharmaceuticals LP
$47
Blueprint Medicines Corporation
$22
GENZYME CORPORATION
$22
Hikma Pharmaceuticals USA
$21
Genentech, Inc.
$17
Genentech USA, Inc.
$15
PFIZER INC.
$15
Amgen Inc.
$14
Top 3 companies account for 58.0% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$849
AstraZeneca Pharmaceuticals LP
$688
CSL Behring
$636
Novartis Pharmaceuticals Corporation
$623
Regeneron Healthcare Solutions, Inc.
$398
BioCryst US Sales Co., LLC
$322
Takeda Pharmaceuticals U.S.A., Inc.
$315
PFIZER INC.
$307
Octapharma USA, Inc.
$208
ADMA BioManufacturing LLC
$160
Teva Pharmaceuticals USA, Inc.
$152
kaleo, Inc.
$139
LEO Pharma Inc.
$128
Genentech USA, Inc.
$126
GENZYME CORPORATION
$105
Blueprint Medicines Corporation
$92
OptiNose US, Inc.
$88
Grifols USA, LLC
$87
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
ALK-Abello, Inc
$71
Amgen Inc.
$70
Pharming Healthcare, Inc.
$60
BioCryst Pharmaceuticals, Inc.
$28
Incyte Corporation
$23
Phadia US Inc.
$21
Hikma Pharmaceuticals USA
$21
Aimmune Therapeutics, Inc.
$18
Shire North American Group Inc
$18
AbbVie Inc.
$17
Covis Pharma GmbH
$17
Genentech, Inc.
$17
SANOFI-AVENTIS U.S. LLC
$16
Kaleo, Inc.
$13
Sunovion Pharmaceuticals Inc.
$11
Top 3 companies account for 36.7% of all-time payments
Associated products mentioned in payments ›
ADBRY · ALVESCO · AUVI-Q · AYVAKIT · AirDuo Digihaler · Auvi-Q · BEVESPI AEROSPHERE · BREO · BREZTRI · CINRYZE · CUTAQUIG · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · EUCRISA · FASENRA · Grastek · Haegarda · Hizentra · ImmunoCAP · NUCALA · OCTAGAM · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORLADEYO · Odactra · PALFORZIA · PANZYGA · PAZEO · Privigen · QVAR · RINVOQ · RUCONEST · Ryaltris · SPIRIVA RESPIMAT · STANDARDIZED · STIOLTO RESPIMAT · SYMBICORT · TAKHZYRO · TEZSPIRE · TIMOTHY · TRELEGY ELLIPTA · Utibron · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an allergy & immunology specialist in Arlington?
Compare allergy & immunologists in the Arlington area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists in nearby ZIP areas
50
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
MEDICAL CITY ARLINGTON
3.3 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Apaliski is an allergy & immunology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Apaliski receive payments from pharmaceutical companies?
Yes. Dr. Apaliski received a total of $5,917 from 34 companies across 266 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Apaliski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Allergy & Immunologists in Arlington
Browse allergy & immunologists in Arlington ranked by procedure volume and transparency data.
Highest volume
Top Allergy & Immunologists in TX
Allergy & immunologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Allergy & Immunologists in TX
Which TX allergy & immunologists receive the most from drug and device companies.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
CSL Behring Payments to Doctors
See all physicians who received payments from CSL Behring.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →